FDA OKs Widened Use of Merck & Co., Inc.'s (JOBS) Isentress HIV Drug

Reuters -- Merck & Co on Thursday said U.S. regulators had widened the approved use of its Isentress HIV treatment to include patients who have not yet been treated for infections with the virus that causes AIDS.